The High Prevalence of Peripheral Neuropathy in Patients with Prediabetes

A group of investigators from the UK recently performed an extensive review of the scientific literature in an attempt to better determine the prevalence of peripheral neuropathy in patients with prediabetes.  Twenty-nine studies (9351 participants) were analyzed.  Their findings were published on May 18, 2021 in the BMJ Open Diabetes Research & Care.

According to the CDC, approximately 88 million American adults-more than 1 in 3-have prediabetes.  This new research would suggest that there are ≥8.8 million Americans with peripheral neuropathy secondary to prediabetes­-making it one of leading causes of peripheral neuropathy in the US.

The mechanism of peripheral neuropathy in prediabetics is likely the same as in diabetics-in that they are both caused by glucose dysmetabolism-with the former being a prodrome of the latter.

Treatment considerations, as with diabetic peripheral neuropathy, should include early adoption of life style changes including diet and exercise modification, vitamin supplementation, medications, physical therapy, and other appropriate therapies.

Dr. Richard H Mann, DABPS, ret

Dr. Richard H Mann, DABPS, ret

Chief Scientific Officer & Founder, Realm Labs, Makers of the NeuRemedy® Product Line of Benfotiamine Nutritional Supplements for Improved Function of the Nerves of the Feet and Legs.*

If you would like to speak with Dr. Mann about how to improve your treatment outcomes on patients with nerve dysfunction in the feet and legs, call 866-634-2745 or email Dr. Mann at realmlabs123@gmail.com.

www.realmlabs.net
Copyright © 2022 Dr. Richard H. Mann